141 related articles for article (PubMed ID: 8459158)
1. [A case of repeated pyoderma gangrenosum with myelodysplastic syndrome].
Aoki M; Miura A; Sato I; Suzuki C
Nihon Naika Gakkai Zasshi; 1993 Jan; 82(1):117-9. PubMed ID: 8459158
[No Abstract] [Full Text] [Related]
2. Multiple nodules on the face and in the nasal cavity are the symptoms of vegetative pyoderma gangrenosum complicated with myelodysplastic syndrome.
Murata J; Sato-Matsumura KC; Nishie W; Mayuzumi M; Kozaki S; Ohnishi K; Shibaki H
Clin Exp Dermatol; 2006 Jan; 31(1):74-6. PubMed ID: 16309489
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of pustular and vegetative pyoderma gangrenosum in a patient with myelodysplastic syndrome.
Omiya W; Ujiie H; Akiyama M; Izumi K; Shigematsu A; Onozawa M; Shimizu H
Eur J Dermatol; 2012; 22(5):711-2. PubMed ID: 22858442
[No Abstract] [Full Text] [Related]
4. Pyoderma gangrenosum and myelodysplastic syndrome.
Litvak D; Kirsner RS; Pakdaman NN; Federman DG
South Med J; 2000 Sep; 93(9):923-5. PubMed ID: 11005358
[TBL] [Abstract][Full Text] [Related]
5. The pseudo-Pelger-Huët anomaly in pyoderma gangrenosum associated with myelodysplastic syndrome.
Chiang M; Fleming M
Am J Dermatopathol; 2007 Jun; 29(3):293-5. PubMed ID: 17519630
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of myelodysplastic syndrome-induced pyoderma gangrenosum.
Koca E; Duman AE; Cetiner D; Buyukasik Y; Haznedaroglu IC; Uner A; Demirhan B; Kerimoglu U; Barista I; Calguneri M; Ozcebe OI
Neth J Med; 2006 Dec; 64(11):422-4. PubMed ID: 17179573
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangrenosum complicated with myelodysplastic syndrome followed by rapidly progressing pyothorax-associated lymphoma: a case report.
Goto A; Yamamoto S; Notoya A; Takada A; Mukai M
Hokkaido Igaku Zasshi; 2006 Jul; 81(4):261-4. PubMed ID: 16892654
[TBL] [Abstract][Full Text] [Related]
8. [Pyoderma gangrenosum aggravated by GM-CSF administration].
Perrot JL; Benoit F; Segault D; Jaubert J; Guyotat D; Claudy A
Ann Dermatol Venereol; 1992; 119(11):846-8. PubMed ID: 1301698
[No Abstract] [Full Text] [Related]
9. Successful treatment with ustekinumab and vacuum-assisted closure therapy in recalcitrant myelodysplastic syndrome-associated pyoderma gangrenosum: case report and literature review.
Nieto D; Sendagorta E; Rueda JM; Herranz P
Clin Exp Dermatol; 2019 Jan; 44(1):116-119. PubMed ID: 29851121
[No Abstract] [Full Text] [Related]
10. Bullous pyoderma gangrenosum in a patient with myelodysplastic syndrome during granulocyte colony-stimulating factor therapy.
Lewerin C; Mobacken H; Nilsson-Ehle H; Swolin B
Leuk Lymphoma; 1997 Aug; 26(5-6):629-32. PubMed ID: 9389372
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of pyoderma gangrenosum associated with myelodysplastic syndrome using high-dose intravenous immunoglobulin.
Tamaki K; Nakazawa T; Mamehara A; Tsuji G; Saigo K; Kawano S; Morinobu A; Kumagai S
Intern Med; 2008; 47(23):2077-81. PubMed ID: 19043265
[TBL] [Abstract][Full Text] [Related]
12. Case records of the Massachusetts General Hospital. Case 1-2012. An 82-year-old man with persistent ulcers on the hands.
Kroshinsky D; Hoang MP; Hasserjian RP
N Engl J Med; 2012 Jan; 366(2):166-74. PubMed ID: 22236228
[No Abstract] [Full Text] [Related]
13. Pyoderma gangrenosum in a child with myelodysplastic syndrome.
Gümrük F; Tuncer MA; Hiĉsönmez G
J Pediatr Hematol Oncol; 2000; 22(4):362-4. PubMed ID: 10959911
[No Abstract] [Full Text] [Related]
14. Erythematous Bullous Patch in a Patient With Myelodysplastic Syndrome: Challenge.
Hong JY; Park KY; Seo SJ
Am J Dermatopathol; 2018 Aug; 40(8):e109-e110. PubMed ID: 28375856
[No Abstract] [Full Text] [Related]
15. Association of pyoderma gangrenosum and sterile osteomyelitis in a patient having myelodysplastic syndrome with der(1;7)(q10;q10).
Yoshida C; Kojima H; Ishigaki T; Katsura Y; Kaneko S; Suzukawa K; Hasegawa Y; Kawachi Y; Otsuka F; Nagasawa T
Eur J Haematol; 2004 Feb; 72(2):149-53. PubMed ID: 14962254
[TBL] [Abstract][Full Text] [Related]
16. Pyoderma gangrenosum following cytosine arabinoside, aclarubicin and granulocyte colony-stimulating factor combination therapy in myelodysplastic syndrome.
Takagi S; Ohsaka A; Taguchi H; Kusama H; Matsuoka T
Intern Med; 1998 Mar; 37(3):316-9. PubMed ID: 9617871
[TBL] [Abstract][Full Text] [Related]
17. Clarithromycin for the treatment of pyoderma gangrenosum associated with myelodysplastic syndrome.
Korekawa A; Nakajima K; Nakano H; Sawamura D
J Dermatol; 2022 Apr; 49(4):e131-e132. PubMed ID: 34862670
[No Abstract] [Full Text] [Related]
18. Pyoderma gangrenosum with myelodysplastic syndrome treated with analogous bone marrow transplantation.
Yamanaka K; Kuniyuki S; Maekawa N; Yoshida Y; Teshima H
Acta Derm Venereol; 2009; 89(1):105-6. PubMed ID: 19197560
[No Abstract] [Full Text] [Related]
19. Use of infliximab in pyoderma gangrenosum.
Hewitt D; Tait C
Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
[TBL] [Abstract][Full Text] [Related]
20. Bullous pyoderma gangrenosum as the presenting sign of fatal acute myelogenous leukemia.
Fox LP; Geyer AS; Husain S; Grossman ME
Leuk Lymphoma; 2006 Jan; 47(1):147-50. PubMed ID: 16321840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
